Angelique Salib provides healthcare regulatory counsel as it relates to compliance, operational and transactional matters through applicable components of the Stark Law, Anti-Kickback Statute, Medicare reimbursement, managed care, in addition to clinical research and life sciences matters. She also works with hospital and health system clients on contractual arrangements, corporate governance and a broad range of compliance matters.
Prior to joining Bass, Berry & Sims, Angelique was an associate at Vedder Price P.C. and McDermott Will & Emery LLP in the firms’ Chicago offices. In both roles she worked with healthcare clients on major transactions and private equity investment deals. Angelique earned her law degree from The University of Chicago Law School where she also earned a Graduate Program in Health Administration and Policy (GPHAP) Certificate and was awarded the Erikson Fellowship for her work at a Chicago-area hospital. Angelique is a member of the American Health Law Association and serves on the Hospitals and Health Systems practice group in the Leadership Development Program.
American Health Law Association (AHLA)
Illinois Association of Healthcare Attorneys
Advise a public university system on compliance with the rules associated with grants and contracts from NIH, NSF, and the Department of Defense
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Representation of Grant Avenue Capital, a healthcare-focused middle-market private equity firm, in its acquisition of Hearts for Hospice, LLC a full-service Utah hospice and home health agency, and Abode Healthcare, Inc., a home health care provider.
Representation of Brookdale Senior Living Inc. (NYSE: BKD) in its definitive agreement to sell 80 percent of Brookdale Health Care Services, the Brentwood-based company’s home health and outpatient therapy division, to HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers, in an all-cash transaction for $400 million
Assisted a prominent children’s hospital with a range of industry-sponsored and investigator-initiated research agreements
Representation of Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its definitive agreement to acquire Queen City Hospice, LLC, and its affiliate Miracle City Hospice, LLC for a cash purchase price of $192.0 million